Clinical Trial Update: Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

View source ↗

Summary

Clinical trial update for the SHERLOCK platform, a high-precision evaluation of minimal residual disease for cancer tracking and interception; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer
• Genitourinary Cancer
• Gynecologic Cancer
• Head and Neck Cancer
• Lung Cancer
• Melanoma
• Pancreatobiliary Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Breast Cancer, Lung Cancer | Status: RECRUITING